Efficacy, safety and immunogenicity of GP2015, an etanercept biosimilar, compared with the reference etanercept in patients with moderate-to-severe rheumatoid arthritis: 24-week results from the comparative phase III, randomised, double-blind EQUIRA study
GP2015（一种依那西普生物类似药）与参考药物依那西普在治疗中重度类风湿性关节炎患者中的疗效、安全性和免疫原性比较：来自比较性 III 期、随机、双盲 EQUIRA 研究的 24 周结果
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2018-000757
Matucci-Cerinic, Marco; Allanore, Yannick; Kavanaugh, Arthur; Buch, Maya H; Schulze-Koops, Hendrik; Kucharz, Eugeniusz J; Woehling, Heike; Babic, Goran; Poetzl, Johann; Davis, Adanna; Schwebig, Arnd
